US FDA greenlights human trials of pig kidneys as 37 million adults suffer from chronic kidney disease

eGenesis has FDA approval for human trials of gene-edited pig kidneys, aiming to treat its first patient this year. This advancement in xenotransplantation offers hope for kidney transplant patients.

Science